APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Growth Hormone Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Growth Hormone Medicine Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchHuman Growth Hormone Medicine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Growth Hormone Medicine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Human Growth Hormone Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Growth Hormone Medicine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Growth Hormone Medicine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Human Growth Hormone Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Growth Hormone Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Growth Hormone Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Growth Hormone Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Growth Hormone Medicine include Teva Pharmaceutical Industries, Novartis AG, Novo Nordisk, Merck & Co., Roche, Eli Lilly & Company, Pfizer Inc., Anhui Anke Biotechnology (Group) Co., Ltd and Ipsen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Growth Hormone Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Growth Hormone Medicine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Growth Hormone Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Growth Hormone Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Growth Hormone Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Growth Hormone Medicine Market by Company

Teva Pharmaceutical Industries

Novartis AG

Novo Nordisk

Merck & Co.

Roche

Eli Lilly & Company

Pfizer Inc.

Anhui Anke Biotechnology (Group) Co., Ltd

Ipsen

Human Growth Hormone Medicine Segment by Type

Powder

Solvent

Human Growth Hormone Medicine Segment by Application

Small For Gestational Age

Turner Syndrome

Growth Hormone Deficiency

Prader-Willi Syndrome

Others

Human Growth Hormone Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Growth Hormone Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Growth Hormone Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Growth Hormone Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Growth Hormone Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Growth Hormone Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Table 2. Major Company of Solvent Table 3. Global Human Growth Hormone Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Growth Hormone Medicine Sales by Type (2021-2026) & (k units) Table 5. Global Human Growth Hormone Medicine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Growth Hormone Medicine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Growth Hormone Medicine Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Growth Hormone Medicine Price by Type (2021-2026) & (US$/unit) Table 9. Global Human Growth Hormone Medicine Sales by Type (2027-2032) & (k units) Table 10. Global Human Growth Hormone Medicine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Growth Hormone Medicine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Growth Hormone Medicine Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Growth Hormone Medicine Price by Type (2027-2032) & (US$/unit) Table 14. North America Human Growth Hormone Medicine Sales by Type (2021-2026) & (k units) Table 15. North America Human Growth Hormone Medicine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Growth Hormone Medicine Sales by Type (2021-2026) & (k units) Table 17. Europe Human Growth Hormone Medicine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Growth Hormone Medicine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Human Growth Hormone Medicine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Growth Hormone Medicine Sales by Type (2021-2026) & (k units) Table 21. Latin America Human Growth Hormone Medicine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Growth Hormone Medicine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Human Growth Hormone Medicine Sales by Type (2021-2026) & (US$ Million) Table 24. Human Growth Hormone Medicine Industry Trends Table 25. Human Growth Hormone Medicine Industry Drivers Table 26. Human Growth Hormone Medicine Industry Opportunities and Challenges Table 27. Human Growth Hormone Medicine Industry Restraints Table 28. Global Human Growth Hormone Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Growth Hormone Medicine Revenue Market Share by Company (2021-2026) Table 30. Global Human Growth Hormone Medicine Sales by Company (2021-2026) & (k units) Table 31. Global Human Growth Hormone Medicine Sales Share by Company (2021-2026) Table 32. Global Human Growth Hormone Medicine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Human Growth Hormone Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Growth Hormone Medicine Major Company Production Sites and Headquarters Table 35. Global Human Growth Hormone Medicine Company, Product Type & Application Table 36. Global Human Growth Hormone Medicine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Growth Hormone Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Growth Hormone Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Growth Hormone Medicine Sales by Region (2021-2026) & (k units) Table 41. Global Human Growth Hormone Medicine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Growth Hormone Medicine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Growth Hormone Medicine Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Growth Hormone Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Human Growth Hormone Medicine Sales by Region (2027-2032) & (k units) Table 46. Global Human Growth Hormone Medicine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Growth Hormone Medicine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Growth Hormone Medicine Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Growth Hormone Medicine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Human Growth Hormone Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Growth Hormone Medicine Sales by Application (2021-2026) & (k units) Table 52. Global Human Growth Hormone Medicine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Growth Hormone Medicine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Growth Hormone Medicine Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Growth Hormone Medicine Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Growth Hormone Medicine Sales by Application (2027-2032) & (k units) Table 57. Global Human Growth Hormone Medicine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Growth Hormone Medicine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Growth Hormone Medicine Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Growth Hormone Medicine Price by Application (2027-2032) & (US$/unit) Table 61. North America Human Growth Hormone Medicine Sales by Application (2021-2026) & (k units) Table 62. North America Human Growth Hormone Medicine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Growth Hormone Medicine Sales by Application (2021-2026) & (k units) Table 64. Europe Human Growth Hormone Medicine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Growth Hormone Medicine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Human Growth Hormone Medicine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Growth Hormone Medicine Sales by Application (2021-2026) & (k units) Table 68. Latin America Human Growth Hormone Medicine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Growth Hormone Medicine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Human Growth Hormone Medicine Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Pharmaceutical Industries Company Information Table 72. Teva Pharmaceutical Industries Business Overview Table 73. Teva Pharmaceutical Industries Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Industries Human Growth Hormone Medicine Product Portfolio Table 75. Teva Pharmaceutical Industries Recent Development Table 76. Novartis AG Company Information Table 77. Novartis AG Business Overview Table 78. Novartis AG Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis AG Human Growth Hormone Medicine Product Portfolio Table 80. Novartis AG Recent Development Table 81. Novo Nordisk Company Information Table 82. Novo Nordisk Business Overview Table 83. Novo Nordisk Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Novo Nordisk Human Growth Hormone Medicine Product Portfolio Table 85. Novo Nordisk Recent Development Table 86. Merck & Co. Company Information Table 87. Merck & Co. Business Overview Table 88. Merck & Co. Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Merck & Co. Human Growth Hormone Medicine Product Portfolio Table 90. Merck & Co. Recent Development Table 91. Roche Company Information Table 92. Roche Business Overview Table 93. Roche Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Roche Human Growth Hormone Medicine Product Portfolio Table 95. Roche Recent Development Table 96. Eli Lilly & Company Company Information Table 97. Eli Lilly & Company Business Overview Table 98. Eli Lilly & Company Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Eli Lilly & Company Human Growth Hormone Medicine Product Portfolio Table 100. Eli Lilly & Company Recent Development Table 101. Pfizer Inc. Company Information Table 102. Pfizer Inc. Business Overview Table 103. Pfizer Inc. Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Pfizer Inc. Human Growth Hormone Medicine Product Portfolio Table 105. Pfizer Inc. Recent Development Table 106. Anhui Anke Biotechnology (Group) Co., Ltd Company Information Table 107. Anhui Anke Biotechnology (Group) Co., Ltd Business Overview Table 108. Anhui Anke Biotechnology (Group) Co., Ltd Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Anhui Anke Biotechnology (Group) Co., Ltd Human Growth Hormone Medicine Product Portfolio Table 110. Anhui Anke Biotechnology (Group) Co., Ltd Recent Development Table 111. Ipsen Company Information Table 112. Ipsen Business Overview Table 113. Ipsen Human Growth Hormone Medicine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Ipsen Human Growth Hormone Medicine Product Portfolio Table 115. Ipsen Recent Development Table 116. North America Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Human Growth Hormone Medicine Sales by Country (2021-2026) & (k units) Table 118. North America Human Growth Hormone Medicine Sales Market Share by Country (2021-2026) Table 119. North America Human Growth Hormone Medicine Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Human Growth Hormone Medicine Sales Market Share Forecast by Country (2027-2032) Table 121. North America Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Human Growth Hormone Medicine Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Human Growth Hormone Medicine Market Share by Country (2021-2026) Table 124. North America Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Human Growth Hormone Medicine Market Share Forecast by Country (2027-2032) Table 126. Europe Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Human Growth Hormone Medicine Sales by Country (2021-2026) & (k units) Table 128. Europe Human Growth Hormone Medicine Sales Market Share by Country (2021-2026) Table 129. Europe Human Growth Hormone Medicine Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Human Growth Hormone Medicine Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Human Growth Hormone Medicine Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Human Growth Hormone Medicine Market Share by Country (2021-2026) Table 134. Europe Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Human Growth Hormone Medicine Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Human Growth Hormone Medicine Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Human Growth Hormone Medicine Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Human Growth Hormone Medicine Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Human Growth Hormone Medicine Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Human Growth Hormone Medicine Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Human Growth Hormone Medicine Market Share by Country (2021-2026) Table 144. Asia-Pacific Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Human Growth Hormone Medicine Market Share Forecast by Country (2027-2032) Table 146. Latin America Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Human Growth Hormone Medicine Sales by Country (2021-2026) & (k units) Table 148. Latin America Human Growth Hormone Medicine Sales Market Share by Country (2021-2026) Table 149. Latin America Human Growth Hormone Medicine Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Human Growth Hormone Medicine Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Human Growth Hormone Medicine Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Human Growth Hormone Medicine Market Share by Country (2021-2026) Table 154. Latin America Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Human Growth Hormone Medicine Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Human Growth Hormone Medicine Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Human Growth Hormone Medicine Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Human Growth Hormone Medicine Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Human Growth Hormone Medicine Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Human Growth Hormone Medicine Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Human Growth Hormone Medicine Market Share by Country (2021-2026) Table 164. Middle East and Africa Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Human Growth Hormone Medicine Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Human Growth Hormone Medicine Distributors List Table 169. Human Growth Hormone Medicine Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Human Growth Hormone Medicine Image Figure 2. Global Human Growth Hormone Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Growth Hormone Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Growth Hormone Medicine Sales (2021-2032) & (k units) Figure 5. Powder Image Figure 6. Global Powder Sales YoY Growth (2021-2032) & (k units) Figure 7. Solvent Image Figure 8. Global Solvent Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Human Growth Hormone Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Growth Hormone Medicine Market Share by Type 2025 VS 2032 Figure 11. North America Human Growth Hormone Medicine Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Growth Hormone Medicine Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Growth Hormone Medicine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Growth Hormone Medicine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Growth Hormone Medicine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Growth Hormone Medicine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Growth Hormone Medicine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Growth Hormone Medicine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Growth Hormone Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Growth Hormone Medicine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Growth Hormone Medicine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Small For Gestational Age Image Figure 24. Global Small For Gestational Age Sales YoY Growth (2021-2032) & (k units) Figure 25. Turner Syndrome Image Figure 26. Global Turner Syndrome Sales YoY Growth (2021-2032) & (k units) Figure 27. Growth Hormone Deficiency Image Figure 28. Global Growth Hormone Deficiency Sales YoY Growth (2021-2032) & (k units) Figure 29. Prader-Willi Syndrome Image Figure 30. Global Prader-Willi Syndrome Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Human Growth Hormone Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Human Growth Hormone Medicine Market Share by Application 2025 VS 2032 Figure 35. North America Human Growth Hormone Medicine Sales Market Share in Volume by Application in 2025 Figure 36. North America Human Growth Hormone Medicine Sales Market Share in Value by Application in 2025 Figure 37. Europe Human Growth Hormone Medicine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Human Growth Hormone Medicine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Human Growth Hormone Medicine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Human Growth Hormone Medicine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Human Growth Hormone Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Human Growth Hormone Medicine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Human Growth Hormone Medicine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Human Growth Hormone Medicine Sales Market Share in Value by Application in 2025 Figure 45. North America Human Growth Hormone Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Human Growth Hormone Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Human Growth Hormone Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Human Growth Hormone Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Growth Hormone Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Human Growth Hormone Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Human Growth Hormone Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Human Growth Hormone Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Growth Hormone Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Human Growth Hormone Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Human Growth Hormone Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Human Growth Hormone Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Growth Hormone Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Human Growth Hormone Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Human Growth Hormone Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Human Growth Hormone Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Growth Hormone Medicine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Human Growth Hormone Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Human Growth Hormone Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Human Growth Hormone Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Human Growth Hormone Medicine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Human Growth Hormone Medicine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Solvent
Applications
  • Small For Gestational Age
  • Turner Syndrome
  • Growth Hormone Deficiency
  • Prader-Willi Syndrome
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Novartis AG
  • Novo Nordisk
  • Merck & Co.
  • Roche
  • Eli Lilly & Company
  • Pfizer Inc.
  • Anhui Anke Biotechnology (Group) Co., Ltd
  • Ipsen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Growth Hormone Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Growth Hormone Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Growth Hormone Medicine Market by Type
  6. 1.3.1 Powder
  7. 1.3.2 Solvent
  8. 1.4 Global Human Growth Hormone Medicine Market Size by Type
  9. 1.4.1 Global Human Growth Hormone Medicine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Growth Hormone Medicine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Growth Hormone Medicine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Growth Hormone Medicine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Growth Hormone Medicine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Growth Hormone Medicine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Growth Hormone Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Growth Hormone Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Growth Hormone Medicine Industry Trends
  2. 2.2 Human Growth Hormone Medicine Industry Drivers
  3. 2.3 Human Growth Hormone Medicine Industry Opportunities and Challenges
  4. 2.4 Human Growth Hormone Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Growth Hormone Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Growth Hormone Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Human Growth Hormone Medicine Price (2021-2026)
  4. 3.4 Global Human Growth Hormone Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Growth Hormone Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Human Growth Hormone Medicine Company, Product Type & Application
  7. 3.7 Global Human Growth Hormone Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Growth Hormone Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Growth Hormone Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Growth Hormone Medicine Tier 1, Tier 2, and Tier 3
4 Human Growth Hormone Medicine Regional Status and Outlook
  1. 4.1 Global Human Growth Hormone Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Growth Hormone Medicine Historic Market Size by Region
  3. 4.2.1 Global Human Growth Hormone Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Growth Hormone Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Growth Hormone Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Growth Hormone Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Human Growth Hormone Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Growth Hormone Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Growth Hormone Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Growth Hormone Medicine by Application
  1. 5.1 Human Growth Hormone Medicine Market by Application
  2. 5.1.1 Small For Gestational Age
  3. 5.1.2 Turner Syndrome
  4. 5.1.3 Growth Hormone Deficiency
  5. 5.1.4 Prader-Willi Syndrome
  6. 5.1.5 Others
  7. 5.2 Global Human Growth Hormone Medicine Market Size by Application
  8. 5.2.1 Global Human Growth Hormone Medicine Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Human Growth Hormone Medicine Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Human Growth Hormone Medicine Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Human Growth Hormone Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Human Growth Hormone Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Human Growth Hormone Medicine Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Human Growth Hormone Medicine Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Human Growth Hormone Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Human Growth Hormone Medicine Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Human Growth Hormone Medicine Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Novo Nordisk
  14. 6.3.1 Novo Nordisk Company Information
  15. 6.3.2 Novo Nordisk Business Overview
  16. 6.3.3 Novo Nordisk Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novo Nordisk Human Growth Hormone Medicine Product Portfolio
  18. 6.3.5 Novo Nordisk Recent Developments
  19. 6.4 Merck & Co.
  20. 6.4.1 Merck & Co. Company Information
  21. 6.4.2 Merck & Co. Business Overview
  22. 6.4.3 Merck & Co. Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co. Human Growth Hormone Medicine Product Portfolio
  24. 6.4.5 Merck & Co. Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Human Growth Hormone Medicine Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Eli Lilly & Company
  32. 6.6.1 Eli Lilly & Company Company Information
  33. 6.6.2 Eli Lilly & Company Business Overview
  34. 6.6.3 Eli Lilly & Company Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly & Company Human Growth Hormone Medicine Product Portfolio
  36. 6.6.5 Eli Lilly & Company Recent Developments
  37. 6.7 Pfizer Inc.
  38. 6.7.1 Pfizer Inc. Company Information
  39. 6.7.2 Pfizer Inc. Business Overview
  40. 6.7.3 Pfizer Inc. Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Inc. Human Growth Hormone Medicine Product Portfolio
  42. 6.7.5 Pfizer Inc. Recent Developments
  43. 6.8 Anhui Anke Biotechnology (Group) Co., Ltd
  44. 6.8.1 Anhui Anke Biotechnology (Group) Co., Ltd Company Information
  45. 6.8.2 Anhui Anke Biotechnology (Group) Co., Ltd Business Overview
  46. 6.8.3 Anhui Anke Biotechnology (Group) Co., Ltd Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Anhui Anke Biotechnology (Group) Co., Ltd Human Growth Hormone Medicine Product Portfolio
  48. 6.8.5 Anhui Anke Biotechnology (Group) Co., Ltd Recent Developments
  49. 6.9 Ipsen
  50. 6.9.1 Ipsen Company Information
  51. 6.9.2 Ipsen Business Overview
  52. 6.9.3 Ipsen Human Growth Hormone Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ipsen Human Growth Hormone Medicine Product Portfolio
  54. 6.9.5 Ipsen Recent Developments
7 North America by Country
  1. 7.1 North America Human Growth Hormone Medicine Sales by Country
  2. 7.1.1 North America Human Growth Hormone Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Growth Hormone Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Human Growth Hormone Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Growth Hormone Medicine Market Size by Country
  6. 7.2.1 North America Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Growth Hormone Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Growth Hormone Medicine Sales by Country
  2. 8.1.1 Europe Human Growth Hormone Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Growth Hormone Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Growth Hormone Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Growth Hormone Medicine Market Size by Country
  6. 8.2.1 Europe Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Growth Hormone Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Growth Hormone Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Human Growth Hormone Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Growth Hormone Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Growth Hormone Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Growth Hormone Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Growth Hormone Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Growth Hormone Medicine Sales by Country
  2. 10.1.1 South America Human Growth Hormone Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Growth Hormone Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Human Growth Hormone Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Growth Hormone Medicine Market Size by Country
  6. 10.2.1 South America Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Growth Hormone Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Growth Hormone Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Human Growth Hormone Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Growth Hormone Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Growth Hormone Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Growth Hormone Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Human Growth Hormone Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Growth Hormone Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Growth Hormone Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Growth Hormone Medicine Value Chain Analysis
  2. 12.1.1 Human Growth Hormone Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Growth Hormone Medicine Production Mode & Process
  7. 12.2 Human Growth Hormone Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Growth Hormone Medicine Distributors
  10. 12.2.3 Human Growth Hormone Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst